-
1
-
-
0037468125
-
Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: High complete response and low toxicity rates
-
10.1038/sj.bjc.6600716 12610501
-
Lin JC Jan JS Hsu CY Jiang RS Wang WY Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: High complete response and low toxicity rates Br J Cancer 2003 88 187-194 10.1038/sj.bjc.6600716 12610501
-
(2003)
Br J Cancer
, vol.88
, pp. 187-194
-
-
Lin, J.C.1
Jan, J.S.2
Hsu, C.Y.3
Jiang, R.S.4
Wang, W.Y.5
-
2
-
-
0037441720
-
Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival
-
10.1200/JCO.2003.06.158 12586799
-
Lin JC Jan JS Hsu CY Liang WM Jiang RS Wang WY Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival J Clin Oncol 2003 21 631-637 10.1200/ JCO.2003.06.158 12586799
-
(2003)
J Clin Oncol
, vol.21
, pp. 631-637
-
-
Lin, J.C.1
Jan, J.S.2
Hsu, C.Y.3
Liang, W.M.4
Jiang, R.S.5
Wang, W.Y.6
-
3
-
-
0038363446
-
Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma
-
10.1002/hed.10238 12784235
-
Lin JC Jan JS Chen KY Hsu CY Liang WM Wang WY Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma Head Neck 2003 25 438-450 10.1002/hed.10238 12784235
-
(2003)
Head Neck
, vol.25
, pp. 438-450
-
-
Lin, J.C.1
Jan, J.S.2
Chen, K.Y.3
Hsu, C.Y.4
Liang, W.M.5
Wang, W.Y.6
-
4
-
-
0031947875
-
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
-
9552031
-
Al-Sarraf M LeBlanc M Giri PG Fu KK Cooper J Vuong T Forastiere AA Adams G Sakr WA Schuller DE Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 J Clin Oncol 1998 16 1310-1317 9552031
-
(1998)
J Clin Oncol
, vol.16
, pp. 1310-1317
-
-
Al-Sarraf, M.1
LeBlanc, M.2
Giri, P.G.3
Fu, K.K.4
Cooper, J.5
Vuong, T.6
Forastiere, A.A.7
Adams, G.8
Sakr, W.A.9
Schuller, D.E.10
-
6
-
-
0027767762
-
Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
-
10.1126/science.7694363 7694363
-
Freeman GJ Gribben JG Boussiotis VA Ng JW Restivo VA Jr Lombard LA Gray GS Nadler LM Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation Science 1993 262 909-911 10.1126/ science.7694363 7694363
-
(1993)
Science
, vol.262
, pp. 909-911
-
-
Freeman, G.J.1
Gribben, J.G.2
Boussiotis, V.A.3
Ng, J.W.4
Restivo Jr., V.A.5
Lombard, L.A.6
Gray, G.S.7
Nadler, L.M.8
-
7
-
-
0024444165
-
B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells
-
2794510
-
Freeman GJ Freedman AS Segil JM Lee G Whitman JF Nadler LM B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells J Immunol 1989 143 2714-2722 2794510
-
(1989)
J Immunol
, vol.143
, pp. 2714-2722
-
-
Freeman, G.J.1
Freedman, A.S.2
Segil, J.M.3
Lee, G.4
Whitman, J.F.5
Nadler, L.M.6
-
8
-
-
0029944533
-
CD28/B7 system of T cell costimulation
-
10.1146/annurev.immunol.14.1.233 8717514
-
Lenschow DJ Walunas TL Bluestone JA CD28/B7 system of T cell costimulation Annu Rev Immunol 1996 14 233-258 10.1146/ annurev.immunol.14.1.233 8717514
-
(1996)
Annu Rev Immunol
, vol.14
, pp. 233-258
-
-
Lenschow, D.J.1
Walunas, T.L.2
Bluestone, J.A.3
-
9
-
-
0026537347
-
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
-
10.1038/356607a0 1313950
-
Harding FA McArthur JG Gross JA Raulet DH Allison JP CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones Nature 1992 356 607-609 10.1038/356607a0 1313950
-
(1992)
Nature
, vol.356
, pp. 607-609
-
-
Harding, F.A.1
McArthur, J.G.2
Gross, J.A.3
Raulet, D.H.4
Allison, J.P.5
-
10
-
-
0028783879
-
Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells
-
1871000 7573360
-
Agathanggelou A Niedobitek G Chen R Nicholls J Yin W Young LS Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells Am J Pathol 1995 147 1152-1160 1871000 7573360
-
(1995)
Am J Pathol
, vol.147
, pp. 1152-1160
-
-
Agathanggelou, A.1
Niedobitek, G.2
Chen, R.3
Nicholls, J.4
Yin, W.5
Young, L.S.6
-
11
-
-
0032972410
-
Increased production of interferon-gamma by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: Indicative of an activated status
-
10.1016/S0304-3835(99)00056-7 10403546
-
Tang KF Chan SH Loh KS Chong SM Wang D Yeoh KH Hu H Increased production of interferon-gamma by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: Indicative of an activated status Cancer Lett 1999 140 93-98 10.1016/S0304-3835(99)00056-7 10403546
-
(1999)
Cancer Lett
, vol.140
, pp. 93-98
-
-
Tang, K.F.1
Chan, S.H.2
Loh, K.S.3
Chong, S.M.4
Wang, D.5
Yeoh, K.H.6
Hu, H.7
-
12
-
-
0038360113
-
-
Philadelphia: Lippincott-Raven 5
-
Fleming ID Cooper JS Henson DE Hutter RV Kennedy BJ Murphy GP O'Sullivan B Sobin LH Yarbro JW Eds AJCC cancer staging manual Philadelphia: Lippincott-Raven 5 1997 31-39
-
(1997)
AJCC Cancer Staging Manual
, pp. 31-39
-
-
Fleming, I.D.1
Cooper, J.S.2
Henson, D.E.3
Hutter, R.V.4
Kennedy, B.J.5
Murphy, G.P.6
O'Sullivan, B.7
Sobin, L.H.8
Yarbro, J.W.9
-
13
-
-
33845971896
-
Endogenous expression of CD80 co-stimulatory molecules facilitates in vivo tumor regression of oral squamous carcinoma
-
17201120
-
Thomas GR Wen J Endogenous expression of CD80 co-stimulatory molecules facilitates in vivo tumor regression of oral squamous carcinoma Anticancer Res 2006 26 4093-4101 17201120
-
(2006)
Anticancer Res
, vol.26
, pp. 4093-4101
-
-
Thomas, G.R.1
Wen, J.2
-
14
-
-
2942607684
-
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma
-
10.1056/NEJMoa032260 15190138
-
Lin JC Wang WY Chen KY Wei YH Liang WM Jan JS Jiang RS Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N Engl J Med 2004 350 2461-2470 10.1056/NEJMoa032260 15190138
-
(2004)
N Engl J Med
, vol.350
, pp. 2461-2470
-
-
Lin, J.C.1
Wang, W.Y.2
Chen, K.Y.3
Wei, Y.H.4
Liang, W.M.5
Jan, J.S.6
Jiang, R.S.7
|